Vanguard Group
SILK

Vanguard Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Vanguard Group’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,970,143
Closed -$80.3M – 4400
2024
Q2 		$80.3M Buy
2,970,143
+47,648
+2% +$991K ﹤0.01% 1940
2024
Q1 		$53.5M Buy
2,922,495
+30,726
+1% +$488K ﹤0.01% 2142
2023
Q4 		$35.5M Sell
2,891,769
-684,732
-19% -$6.42M ﹤0.01% 2327
2023
Q3 		$53.6M Buy
3,576,501
+262
+0% +$5.45K ﹤0.01% 2098
2023
Q2 		$116M Sell
3,576,239
-65,749
-2% -$2.4M ﹤0.01% 1771
2023
Q1 		$143M Buy
3,641,988
+79,878
+2% +$3.91M ﹤0.01% 1633
2022
Q4 		$188M Buy
3,562,110
+366,822
+11% +$17.9M 0.01% 1469
2022
Q3 		$144M Buy
3,195,288
+38,613
+1% +$1.66M ﹤0.01% 1585
2022
Q2 		$115M Buy
3,156,675
+131,292
+4% +$4.77M ﹤0.01% 1737
2022
Q1 		$125M Sell
3,025,383
-5,983
-0.2% -$211K ﹤0.01% 1818
2021
Q4 		$129M Buy
3,031,366
+4,062
+0.1% +$203K ﹤0.01% 1841
2021
Q3 		$167M Sell
3,027,304
-4,531
-0.1% -$237K ﹤0.01% 1705
2021
Q2 		$145M Buy
3,031,835
+80,354
+3% +$4.09M ﹤0.01% 1803
2021
Q1 		$149M Buy
2,951,481
+95,615
+3% +$5.31M ﹤0.01% 1735
2020
Q4 		$180M Buy
2,855,866
+74,521
+3% +$4.62M 0.01% 1519
2020
Q3 		$187M Buy
2,781,345
+144,795
+5% +$7.9M 0.01% 1326
2020
Q2 		$110M Buy
2,636,550
+985,681
+60% +$37.8M ﹤0.01% 1621
2020
Q1 		$52M Buy
1,650,869
+119,433
+8% +$4.78M ﹤0.01% 1853
2019
Q4 		$61.8M Buy
1,531,436
+574,793
+60% +$20.1M ﹤0.01% 2000
2019
Q3 		$31.1M Buy
956,643
+425,371
+80% +$16.9M ﹤0.01% 2280
2019
Q2 		$25.7M Buy
+531,272
New +$22.6M ﹤0.01% 2386

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vanguard Group's SILK Position: Q3 2024 in Review

Vanguard Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 2,970,143 shares — an estimated $80.3M sold.

Vanguard Group first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $188M in Q4 2022. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Vanguard Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Vanguard Group sold 2,970,143 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $80.3M.
  • Vanguard Group first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
  • Vanguard Group's Silk Road Medical, Inc. Common Stock position peaked at $188M in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Vanguard Group's 13F filing for Q3 2024, filed 13 Nov 2024.